scholarly journals Characteristics of neutron capture therapy in terms of biology for tumor therapy and radiation oncology（Review Article）

2016 ◽  
Vol 28 (3) ◽  
pp. 134-147
Author(s):  
Shin-ichiro Masunaga ◽  
Minoru Suzuki ◽  
Keizo Tano ◽  
Yu Sanada ◽  
Koji Ono
Keyword(s):  
Radiation Oncology ◽  
Neutron Capture ◽  
Tumor Therapy ◽  
Review Article ◽  
Neutron Capture Therapy ◽  
Oncology Review

Polyhedral boron derivatives of porphyrins and phthalocyanines

2001 ◽  
Vol 05 (11) ◽  
pp. 767-781 ◽  
Author(s):  
VLADIMIR I. BREGADZE ◽  
IGOR B. SIVAEV ◽  
DETLEF GABEL ◽  
DIETER WÖHRLE
Keyword(s):  
Neutron Capture ◽  
Tumor Therapy ◽  
The Other ◽  
Medical Applications ◽  
Neutron Capture Therapy ◽  
Current Interest ◽  
Boron Compounds ◽  
Other Hand ◽  
The One ◽  
Derivatives Of

The synthesis of compounds containing polyhedral boron cages and porphyrin or phthalocyanine units connected covalently in one molecule is reviewed. The importance of these compounds arises, on the one hand, from the use of polyhedral boron derivatives in neutron capture therapy for cancer; on the other hand, porphyrins and phthalocyanines are known as photosensitizers in photodynamic tumor therapy. Current interest in the binding of polyhedral boron compounds to porphyrins and phthalocyanines is due to the observation that porphyrins and phthalocyanines show improved uptake and good persistence in tissues. Medical applications of compounds containing polyhedral boron cages and porphyrin or phthalocyanine units in one molecule are briefly discussed.

Reactions of oxonium derivatives of (B12H12)2- with phenoles, and synthesis and photochemical properties of a phthalocyanine containing four (B12H12)2- groups

2006 ◽  
Vol 10 (11) ◽  
pp. 1293-1300 ◽  
Author(s):  
Andrej Semioshkin ◽  
Olga Tsaryova ◽  
Olga Zhidkova ◽  
Vladimir Bregadze ◽  
Dieter Wöhrle
Keyword(s):  
Photocatalytic Activity ◽  
Neutron Capture ◽  
Tumor Therapy ◽  
High Yield ◽  
Neutron Capture Therapy ◽  
Boron Neutron Capture ◽  
Oxonium Derivatives ◽  
Photochemical Properties ◽  
High Yields ◽  
Derivatives Of

The reactions of dodecahydro-closo-dodecaborate oxonium derivatives with various phenols resulted in phenoxy-undecahydro-closo-dodecaborates in high yields. Using this method, a phthalocyanine zinc(II) complex containing four ( B 12 H 12)2- species was prepared in high yield. The compound shows good photocatalytic activity. The combination of boron cages and phthalocyanines makes this compound useful for boron neutron capture therapy for cancer and photodynamic tumor therapy.

scholarly journals The basis and advances in clinical application of boron neutron capture therapy

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Huifang He ◽  
Jiyuan Li ◽  
Ping Jiang ◽  
Suqing Tian ◽  
Hao Wang ◽  
...  
Keyword(s):  
Boron Neutron Capture Therapy ◽  
Radiation Oncology ◽  
Neutron Capture ◽  
Normal Tissue ◽  
Neutron Capture Therapy ◽  
Thermal Neutrons ◽  
Neutron Sources ◽  
Boron Neutron Capture ◽  
High Linear Energy Transfer ◽  
Α Particles

AbstractBoron neutron capture therapy (BNCT) was first proposed as early as 1936, and research on BNCT has progressed relatively slowly but steadily. BNCT is a potentially useful tool for cancer treatment that selectively damages cancer cells while sparing normal tissue. BNCT is based on the nuclear reaction that occurs when 10B capture low-energy thermal neutrons to yield high-linear energy transfer (LET) α particles and recoiling 7Li nuclei. A large number of 10B atoms have to be localized within the tumor cells for BNCT to be effective, and an adequate number of thermal neutrons need to be absorbed by the 10B atoms to generate lethal 10B (n, α)7Li reactions. Effective boron neutron capture therapy cannot be achieved without appropriate boron carriers. Improvement in boron delivery and the development of the best dosing paradigms for both boronophenylalanine (BPA) and sodium borocaptate (BSH) are of major importance, yet these still have not been optimized. Here, we present a review of this treatment modality from the perspectives of radiation oncology, biology, and physics. This manuscript provides a brief introduction of the mechanism of cancer-cell-selective killing by BNCT, radiobiological factors, and progress in the development of boron carriers and neutron sources as well as the results of clinical study.

scholarly journals Diketopyrrolopyrrole Fluorescent Probes, Photophysical and Biological Applications

Chemosensors ◽  
2021 ◽  
Vol 9 (3) ◽  
pp. 44
Author(s):  
Muhammad Aminu Auwalu ◽  
Shanshan Cheng
Keyword(s):  
Quantum Yield ◽  
Fluorescent Probes ◽  
Organic Dyes ◽  
Tumor Therapy ◽  
Research Area ◽  
Research Field ◽  
Review Article ◽  
Biological Applications ◽  
Chemistry Research ◽  
Cancer Tumor

Biological applications of fluorescent probes are rapidly increasing in the supramolecular chemistry research field. Several organic dyes are being utilized currently in developing and advancing this attractive research area, of which diketopyrrolopyrrole (DPP) organic dyes show an exceptional photophysical features (high-fluorescence quantum yield (FQY), good photochemical and thermal stability) that are essential properties for biological applications. Great efforts have been made in recent years towards developing novel fluorescent DPPs by different chemists for such applications, and some positive results have been reported. As a result, this review article gives an account of the progress that has so far been made very recently, mainly within the last decade, in that we selectively focus on and discuss more from 2015 to present on some recent scholarly achievements of fluorescent DPPs: quantum yield, aggregation-induced emission (AIE), solid-state emission, bio-imaging, cancer/tumor therapy, mitochondria staining and some polymeric fluorescent DPPs. Finally, this review article highlights researchers working on luminescent DPPs and the future prospects in some key areas towards designing DPP-based fluorescent probes in order to boost their photophysical and biological applications more effectively.

scholarly journals HGG-05. REGRESSION OF RECURRENT GLIOBLASTOMA AFTER BORON NEUTRON CAPTURE THERAPY AND CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN A CHILD

2020 ◽  
Vol 22 (Supplement_3) ◽  
pp. iii345-iii345
Author(s):  
Hsin-Hung Chen ◽  
Yi-Wei Chen
Keyword(s):  
T Cells ◽  
T Cell ◽  
Chimeric Antigen Receptor ◽  
Boron Neutron Capture Therapy ◽  
Neutron Capture ◽  
Antigen Receptor ◽  
Neutron Capture Therapy ◽  
T Cell Therapy ◽  
Boron Neutron Capture ◽  
Car T

Abstract A 6 y/o girl with recurrent multifocal glioblastoma received 3 times of boron neutron capture therapy (BNCT) and chimeric antigen receptor (CAR)–engineered T cells targeting the tumor-associated antigen HER2. Multiple infusions of CAR T cells were administered over 30 days through intraventricular delivery routes. It was not associated with any toxic effects of grade 3 or higher. After BNCT and CAR T-cell treatment, regression of all existing intracranial lesions were observed, along with corresponding increases in levels of cytokines and immune cells in the cerebrospinal fluid, but new lesions recurred soon after the treatment. This clinical response continued for 14 months after the initiation of first recurrence.

Sign in / Sign up

Export Citation Format

Share Document